All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors could effectively reduce HbA(1C) and postprandial hyperglycemia and could incur only minimal danger of hypoglycemia. Patients with uncontrolled diabetes might be treated by the complementary action of insulin plus DPP-4 inhibitors. Here, we compa...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Endocr Disord
Main Authors: Yen, Fu-Shun, Chiang, Jen-Huai, Hwu, Chii-Min, Yen, Yu-Hsin, Lin, Boniface J., Wei, James Cheng-Chung, Hsu, Chih-Cheng
格式: Artigo
語言:Inglês
出版: BioMed Central 2019
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321656/
https://ncbi.nlm.nih.gov/pubmed/30611254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0330-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍